A gene expression classifier of node-positive colorectal cancer

Neoplasia

Volumn 11, Issue 10, 2009, Pages 1074-1083

  Meeh, Paul F ^a   Farrell, Christopher L ^a   Croshaw, Randal ^a   Crimm, Hampton ^a   Miller, Samantha K ^a   Oroian, Dora ^a   Kowli, Sangeeta ^a   Zhu, Jinyu ^a   Carver, Wayne ^a   Wu, Wensong ^b   Pena, Edsel ^b   Buckhaults, Phillip J ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FIBRONECTIN;

ARTICLE; CANCER INVASION; CELL MIGRATION; COLORECTAL CANCER; CONTROLLED STUDY; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SERIAL ANALYSIS OF GENE EXPRESSION;

EID: 70149095239     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.09808     Document Type: Article

References (39)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, and Thun MJ (2008). Cancer statistics, 2008. CA Cancer J Clin 58 (2), 71-96.
2. Govindarajan A and Baxter NN (2008). Lymph node evaluation in early-stage colon cancer. Clin Colorectal Cancer 7 (4), 240-246.
3. Baxter NN, Virnig DJ, Rothenberger DA, Morris AM, Jessurun J, and Virnig BA (2005). Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst 97 (3), 219-225. (Pubitemid 40277372)
4. Kwon HC, Kim SH, Roh MS, Kim JS, Lee HS, Choi HJ, Jeong JS, Kim HJ, and Hwang TH (2004). Gene expression profiling in lymph node-positive and lymph node-negative colorectal cancer. Dis Colon Rectum 47 (2), 141-152. (Pubitemid 38166617)
5. Croner RS, Peters A, Brueckl WM, Matzel KE, Klein-Hitpass L, Brabletz T, Papadopoulos T, Hohenberger W, Reingruber B, and Lausen B (2005). Microarray versus conventional prediction of lymph node metastasis in colorectal carcinoma. Cancer 104 (2), 395-404. (Pubitemid 40993269)
6. Grade M, Hormann P, Becker S, Hummon AB, Wangsa D, Varma S, Simon R, Liersch T, Becker H, Difilippantonio MJ, et al. (2007). Gene expression profiling reveals a massive, aneuploidy-dependent transcriptional deregulation and distinct differences between lymph node-negative and lymph node-positive colon carcinomas. Cancer Res 67 (1), 41-56. (Pubitemid 46142758)
7. Kim HN, Choi DW, Lee KT, Lee JK, Heo JS, Choi SH, Paik SW, Rhee JC, and Lowe AW (2007). Gene expression profiling in lymph node-positive and lymph node-negative pancreatic cancer. Pancreas 34 (3), 325-334. (Pubitemid 46588258)
8. Nguyen ST, Hasegawa S, Tsuda H, Tomioka H, Ushijima M, Noda M, Omura K, and Miki Y (2007). Identification of a predictive gene expression signature of cervical lymph node metastasis in oral squamous cell carcinoma. Cancer Sci 98 (5), 740-746. (Pubitemid 46563452)
9. Abba MC, Sun H, Hawkins KA, Drake JA, Hu Y, Nunez MI, Gaddis S, Shi T, Horvath S, Sahin A, et al. (2007). Breast cancer molecular signatures as determined by SAGE: correlation with lymph node status. Mol Cancer Res 5 (9), 881-890. (Pubitemid 47416665)
10. Ihaka R and Gentleman R (1996). R: a language for data analysis and graphics. J Comput Graph Stat 5, 299-314.
11. McCullagh P and Nelder J (1983). Generalized Linear Models. London, UK: Chapman & Hall.
12. Dechantsreiter MA, Planker E, Matha B, Lohof E, Holzemann G, Jonczyk A, Goodman SL, and Kessler H (1999). N-methylated cyclic RGD peptides as highly active and selective α(V)β(3) integrin antagonists. J Med Chem 42 (16), 3033-3040.
13. 5 and inhibits retinal pigment epithelium cell attachment, migration and invasion. BMC Ophthalmol 5, 16.
14. Bonferroni CE (1935). Il calcolo delle assicurazioni su gruppi di teste. Studi in Onore del Professore Salvatore Ortu Carboni. Rome, Italy, pp. 13-60.
15. Sarli L, Bader G, Iusco D, Salvemini C, Mauro DD, Mazzeo A, Regina G, and Roncoroni L (2005). Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer. Eur J Cancer 41 (2), 272-279. (Pubitemid 40126960)
16. Clark EA, Golub TR, Lander ES, and Hynes RO (2000). Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406 (6795), 532-535.
17. + isoforms by human and experimental colorectal cancer. Contribution of cancer cells and tumor-associated myofibroblasts. Am J Pathol 148 (2), 579-592.
18. Quasar Collaborative, Gray GR, Barnwell J, McConkey C, Hills RK, Williams NS, and Kerr DJ (2007). Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet 370 (9604), 2020-2029. (Pubitemid 350236339)
19. Farrell C, Crimm H, Meeh P, Croshaw R, Barber T, Vandersteenhoven J, Butler W, and Buckhaults P (2008). Somatic mutations to CSMD1 in colorectal adenocarcinomas. Cancer Biol Ther 7, 609-613. (Pubitemid 351847040)
20. Hanamura N, Yoshida T, Matsumoto E, Kawarada Y, and Sakakura T (1997). Expression of fibronectin and tenascin-C mRNA by myofibroblasts, vascular cells and epithelial cells in human colon adenomas and carcinomas. Int J Cancer 73 (1), 10-15. (Pubitemid 27445983)
21. Vachon PH, Simoneau A, Herring-Gillam FE, and Beaulieu JF (1995). Cellular fibronectin expression is down-regulated at the mRNA level in differentiating human intestinal epithelial cells. Exp Cell Res 216 (1), 30-34.
22. Helleman J, Jansen MP, Span PN, van Staveren IL, Massuger LF, Meijer-van Gelder ME, Sweep FC, Ewing PC, van der Burg ME, Stoter G, et al. (2006). Molecular profiling of platinum resistant ovarian cancer. Int J Cancer 118 (8), 1963-1971.
23. Helleman J, Jansen MP, Ruigrok-Ritstier K, van Staveren IL, Look MP, Meijervan Gelder ME, Sieuwerts AM, Klijn JG, Sleijfer S, Foekens JA, et al. (2008). Association of an extracellular matrix gene cluster with breast cancer prognosis and endocrine therapy response. Clin Cancer Res 14 (17), 5555-5564.
24. Lossos IS, Czerwinski DK, Alizadeh AA, Wechser MA, Tibshirani R, Botstein D, and Levy R (2004). Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med 350 (18), 1828-1837. (Pubitemid 38917249)
25. Nabeshima K, Inoue T, Shimao Y, Kataoka H, and Koono M (1999). Cohort migration of carcinoma cells: differentiated colorectal carcinoma cells move as coherent cell clusters or sheets. Histol Histopathol 14 (4), 1183-1197. (Pubitemid 29447460)
26. Polakis P (2007). The many ways of Wnt in cancer. Curr Opin Genet Dev 17 (1), 45-51.
27. Chen X, Halberg RB, Burch RP, and Dove WF (2008). Intestinal adenomagenesis involves core molecular signatures of the epithelial-mesenchymal transition. J Mol Histol 39 (3), 283-294.
28. Gradl D, Kuhl M, and Wedlich D (1999). The Wnt/Wg signal transducer β-catenin controls fibronectin expression. Mol Cell Biol 19 (8), 5576-5587. (Pubitemid 29339915)
29. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, and Kinzler KW (1997). Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC [see comment]. Science 275 (5307), 1787-1790. (Pubitemid 27136715)
30. Amen M, Liu X, Vadlamudi U, Elizondo G, Diamond E, Engelhardt JF, and Amendt BA (2007). PITX2 and β-catenin interactions regulate Lef-1 isoform expression. Mol Cell Biol 27 (21), 7560-7573. (Pubitemid 350033661)
31. Vadlamudi U, Espinoza HM, Ganga M, Martin DM, Liu X, Engelhardt JF, and Amendt BA (2005). PITX2, β-catenin and LEF-1 interact to synergistically regulate the LEF-1 promoter. J Cell Sci 118 (Pt 6), 1129-1137. (Pubitemid 40528684)
32. Buckhaults P (2006). Gene expression determinants of clinical outcome. Curr Opin Oncol 18 (1), 57-61. (Pubitemid 43740451)
33. Buckhaults P, Rago C, St Croix B, Romans KE, Saha S, Zhang L, Vogelstein B, and Kinzler KW (2001). Secreted and cell surface genes expressed in benign and malignant colorectal tumors. Cancer Res 61 (19), 6996-7001. (Pubitemid 32946484)
34. Buckhaults P, Zhang Z, Chen YC, Wang TL, St Croix B, Saha S, Bardelli A, Morin PJ, Polyak K, Hruban RH, et al. (2003). Identifying tumor origin using a gene expression-based classification map. Cancer Res 63 (14), 4144-4149. (Pubitemid 36917939)
35. Notterman DA, Alon U, Sierk AJ, and Levine AJ (2001). Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res 61 (7), 3124-3130. (Pubitemid 32691964)
36. Eschrich S, Yang I, Bloom G, Kwong KY, Boulware D, Cantor A, Coppola D, Kruhoffer M, Aaltonen L, Orntoft TF, et al. (2005). Molecular staging for survival prediction of colorectal cancer patients. J Clin Oncol 23 (15), 3526-3535. (Pubitemid 46243497)
37. Ruoslahti E (1999). Fibronectin and its integrin receptors in cancer. Adv Cancer Res 76, 1-20.
38. Jan Y, Matter M, Pai JT, Chen YL, Pilch J, Komatsu M, Ong E, Fukuda M, and Ruoslahti E (2004). A mitochondrial protein, Bit1, mediates apoptosis regulated by integrins and Groucho/TLE corepressors. Cell 116 (5), 751-762. (Pubitemid 38326732)
39. Haier J, Goldmann U, Hotz B, Runkel N, and Keilholz U (2002). Inhibition of tumor progression and neoangiogenesis using cyclic RGD-peptides in a chemically induced colon carcinoma in rats. Clin Exp Metastasis 19 (8), 665-672. (Pubitemid 36092261)